Topics

Articles

How drugmakers can navigate the program’s pricing challenges and regulatory developments.

A 340B Navigation Guide for Pharmaceutical Manufacturers

Shift focus in orphan and ultra-orphan messaging to clinical benefit.

The Payer Value Deficit in Orphan Drugs

The August issue varies in subject matters, from the outlook for drug wholesaling to the value of a user-centric approach for drug adherence.

Telling the 'Whole' Story

As Pharma Commerce continues to increase its conference exposure, it all could not have been possible without the help of colleagues. 

Collaboration at the Forefront

The importance of industry, as it moves forward, in focusing on patient-centered care and prioritizing patient needs across the supply chain.  

Patient Centricity in the Pharma Supply Chain

Micah Litow, Kalderos’ president and COO, discusses the importance of identifying and resolving noncompliant discount requests, along with addressing the gross-to-net gap for drug manufacturers.

Addressing Revenue Leakage

The legislation’s deadline for compliance is knocking on the door. Pharma Commerce offers a synopsis of how the Drug Supply Chain Security Act has progressed over the past decade.

DSCSA: A Fast-Approaching Deadline

The publication's June installment features a plethora of coverage, ranging from the learning curve in digital adoption to an overview of the CVD market. 

Operational Trends Surrounding the Pharma Sales Process

As the brand looks to increase its coverage, Pharma Commerce welcomes a pair of editorial contributors to the team.

New Insights, Fresh Voices

Although there is no ‘one size fits all’ solution, the process is influenced by factors such as lifestyle stage, competitive outlook, and market constraints.

Opinion